CNTA
Price
$15.41
Change
-$0.07 (-0.45%)
Updated
Jul 25 closing price
Capitalization
2.06B
23 days until earnings call
CRNX
Price
$30.99
Change
+$0.58 (+1.91%)
Updated
Jul 25 closing price
Capitalization
2.9B
12 days until earnings call
Interact to see
Advertisement

CNTA vs CRNX

Header iconCNTA vs CRNX Comparison
Open Charts CNTA vs CRNXBanner chart's image
Centessa Pharmaceuticals
Price$15.41
Change-$0.07 (-0.45%)
Volume$355.82K
Capitalization2.06B
Crinetics Pharmaceuticals
Price$30.99
Change+$0.58 (+1.91%)
Volume$737.32K
Capitalization2.9B
CNTA vs CRNX Comparison Chart in %
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. CRNX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and CRNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CNTA: $15.41 vs. CRNX: $30.99)
Brand notoriety: CNTA and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 35% vs. CRNX: 100%
Market capitalization -- CNTA: $2.06B vs. CRNX: $2.9B
CNTA [@Biotechnology] is valued at $2.06B. CRNX’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • CNTA’s TA Score: 5 bullish, 4 bearish.
  • CRNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNTA is a better buy in the short-term than CRNX.

Price Growth

CNTA (@Biotechnology) experienced а -1.78% price change this week, while CRNX (@Biotechnology) price change was -0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CNTA is expected to report earnings on Nov 17, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.9B) has a higher market cap than CNTA($2.06B). CNTA YTD gains are higher at: -8.000 vs. CRNX (-39.390). CNTA has higher annual earnings (EBITDA): -208.73M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. CNTA (285M). CRNX has less debt than CNTA: CRNX (50.8M) vs CNTA (118M). CNTA has higher revenues than CRNX: CNTA (15M) vs CRNX (760K).
CNTACRNXCNTA / CRNX
Capitalization2.06B2.9B71%
EBITDA-208.73M-373.49M56%
Gain YTD-8.000-39.39020%
P/E RatioN/AN/A-
Revenue15M760K1,974%
Total Cash285M1.27B22%
Total Debt118M50.8M232%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTACRNX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBLAX14.81N/A
N/A
Hartford Balanced Income A
HGHYX41.13N/A
N/A
Hartford Healthcare Y
HISVX39.99N/A
N/A
Harbor Small Cap Value Investor
MMYLX9.10N/A
N/A
MassMutual Small Company Val Adm
BGCSX15.98N/A
N/A
Baillie Gifford EAFE Plus All Cap I

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with NRIX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.45%
NRIX - CNTA
48%
Loosely correlated
-0.09%
CRNX - CNTA
47%
Loosely correlated
+1.91%
XENE - CNTA
44%
Loosely correlated
-2.29%
IMCR - CNTA
43%
Loosely correlated
-0.28%
OCUL - CNTA
42%
Loosely correlated
+2.43%
More